Physician profile
Danielle Urig
NPI 1194313585
$2,063.04
in general payments reported to CMS, 2019-2025
18 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $153 · 2022: $526 · 2023: $892 · 2024: $293 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,383.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $558.85 | 2022-2024 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Heartmate Touch |
| Astrazeneca Pharmaceuticals LP | $313.72 | 2021-2023 | Farxiga |
| Novartis Pharmaceuticals Corporation | $154.50 | 2021-2023 | |
| Alnylam Pharmaceuticals INC. | $140.62 | 2021-2024 | Amvuttra |
| Abiomed | $139.08 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $110.06 | 2023-2024 | Lifevest |
| Scpharmaceuticals INC. | $109.92 | 2023-2024 | |
| Actelion Pharmaceuticals US, INC. | $80.56 | 2023-2024 | Uptravi |
| Kestra Medical Technology Services, INC. | $74.44 | 2023 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $60.84 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $60.53 | 2021-2023 | Verquvo |
| Boston Scientific Corporation | $59.24 | 2025 | General - Therapies |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.70 | 2022-2023 | Jardiance |
| Vifor Pharma, INC. | $43.47 | 2023 | Veltassa |
| Lexicon Pharmaceuticals, INC. | $36.60 | 2023 | Inpefa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $28.96 | 2021 | |
| Medtronic, INC. | $23.09 | 2023 | Linq II |
| Lilly USA, LLC | $13.86 | 2024 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Urig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.